URL has been copied successfully!
URL has been copied successfully!
Skip to content
JBizNews
Primary Navigation Menu
Menu
Home
Breaking News
Top News
Markets
Crypto
Health
Real Estate
Events
Subscribe
About JBizNews
Search for:
Search Button
Genmab A/S (GMAB) Rating Lifted by Goldman Sachs on Strong 2026 Catalyst Outlook
By:
Yahoo News
On:
April 24, 2026
URL has been copied successfully!
Please follow us:
2026-04-24
Previous Post:
ADMA Biologics, Inc. (ADMA) Initiated at Buy as Canaccord Cites Improving Revenue and Margin Trends
Next Post:
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma